pubmed-article:21620496 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21620496 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
pubmed-article:21620496 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
pubmed-article:21620496 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
pubmed-article:21620496 | lifeskim:mentions | umls-concept:C0027946 | lld:lifeskim |
pubmed-article:21620496 | lifeskim:mentions | umls-concept:C0522510 | lld:lifeskim |
pubmed-article:21620496 | lifeskim:mentions | umls-concept:C0443264 | lld:lifeskim |
pubmed-article:21620496 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:21620496 | pubmed:dateCreated | 2011-6-6 | lld:pubmed |
pubmed-article:21620496 | pubmed:abstractText | Initial promising results of 3D conformal neutron radiotherapy (3D-CNRT) were subsequently limited by high normal tissue toxicities. It is now possible to deliver intensity modulated neutron radiotherapy (IMNRT). The present work compares photon IMRT, 3D-CNRT and IMNRT for three prostate patients to quantify the benefits of IMNRT. | lld:pubmed |
pubmed-article:21620496 | pubmed:language | eng | lld:pubmed |
pubmed-article:21620496 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21620496 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21620496 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21620496 | pubmed:month | May | lld:pubmed |
pubmed-article:21620496 | pubmed:issn | 1879-0887 | lld:pubmed |
pubmed-article:21620496 | pubmed:author | pubmed-author:SnyderMichael... | lld:pubmed |
pubmed-article:21620496 | pubmed:author | pubmed-author:BurmeisterJay... | lld:pubmed |
pubmed-article:21620496 | pubmed:author | pubmed-author:JoinerMichael... | lld:pubmed |
pubmed-article:21620496 | pubmed:author | pubmed-author:KonskiAndreA | lld:pubmed |
pubmed-article:21620496 | pubmed:author | pubmed-author:BossenbergerT... | lld:pubmed |
pubmed-article:21620496 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Ireland Ltd. All rights reserved. | lld:pubmed |
pubmed-article:21620496 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21620496 | pubmed:volume | 99 | lld:pubmed |
pubmed-article:21620496 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21620496 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21620496 | pubmed:pagination | 201-6 | lld:pubmed |
pubmed-article:21620496 | pubmed:meshHeading | pubmed-meshheading:21620496... | lld:pubmed |
pubmed-article:21620496 | pubmed:meshHeading | pubmed-meshheading:21620496... | lld:pubmed |
pubmed-article:21620496 | pubmed:meshHeading | pubmed-meshheading:21620496... | lld:pubmed |
pubmed-article:21620496 | pubmed:meshHeading | pubmed-meshheading:21620496... | lld:pubmed |
pubmed-article:21620496 | pubmed:meshHeading | pubmed-meshheading:21620496... | lld:pubmed |
pubmed-article:21620496 | pubmed:meshHeading | pubmed-meshheading:21620496... | lld:pubmed |
pubmed-article:21620496 | pubmed:meshHeading | pubmed-meshheading:21620496... | lld:pubmed |
pubmed-article:21620496 | pubmed:meshHeading | pubmed-meshheading:21620496... | lld:pubmed |
pubmed-article:21620496 | pubmed:meshHeading | pubmed-meshheading:21620496... | lld:pubmed |
pubmed-article:21620496 | pubmed:meshHeading | pubmed-meshheading:21620496... | lld:pubmed |
pubmed-article:21620496 | pubmed:meshHeading | pubmed-meshheading:21620496... | lld:pubmed |
pubmed-article:21620496 | pubmed:meshHeading | pubmed-meshheading:21620496... | lld:pubmed |
pubmed-article:21620496 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21620496 | pubmed:articleTitle | Dose escalation in prostate cancer using intensity modulated neutron radiotherapy. | lld:pubmed |
pubmed-article:21620496 | pubmed:affiliation | Karmanos Cancer Center, Wayne State University School of Medicine, Detroit, MI, USA. snyderm@karmanos.org | lld:pubmed |
pubmed-article:21620496 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21620496 | pubmed:publicationType | Comparative Study | lld:pubmed |